NFKB1 and depressive disorder: EGCG alleviates CUMS‐induced activation of the NF‐κB signaling pathway and pyroptosis in rat liver and brain tissues, reducing liver injury and improving blood lipid abnormalities, thereby ameliorating depression‐like behaviors.